Literature DB >> 1566750

Muir-Torre syndrome in patients with hematologic malignancies.

P R Cohen1.   

Abstract

The Muir-Torre syndrome (MTS) is defined as the concurrent or sequential discovery of at least one sebaceous gland tumor and a minimum of one internal malignancy. A man with Hodgkin's lymphoma who subsequently developed an ocular sebaceous carcinoma in situ is described and the world literature of patients with the MTS and hematologic malignancies is reviewed.

Entities:  

Mesh:

Year:  1992        PMID: 1566750     DOI: 10.1002/ajh.2830400114

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Muir-Torre Syndrome: expanding the genotype and phenotype--a further family with a MSH6 mutation.

Authors:  H R Murphy; R Armstrong; D Cairns; K L Greenhalgh
Journal:  Fam Cancer       Date:  2008-01-31       Impact factor: 2.375

2.  Multicentric sebaceous gland carcinoma of the lid?

Authors:  H von Below; G E Rose; A C McCartney; J E Wright
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

3.  Genetic predispositions to childhood leukemia.

Authors:  Elliot Stieglitz; Mignon L Loh
Journal:  Ther Adv Hematol       Date:  2013-08

4.  Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme.

Authors:  Deric M Park; Gabrielle A Yeaney; Ronald L Hamilton; Jennifer Mabold; Nikki Urban; Leonard Appleman; John Flickinger; Frank Lieberman; Arlan Mintz
Journal:  Neuro Oncol       Date:  2008-11-21       Impact factor: 12.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.